Johns Hopkins Gynecology And Obstetrics

[Eryn]

Therenowned team of the Johns Hopkins Department of Gynecology and Obstetrics offers a breadth of gynecologic and obstetric specialties including fetal therapy, gynecologic oncology and maternal-fetal medicine. Our experts use the most advanced treatment techniques to deliver personalized care. We are also research and education leaders committed to advancing the field of gynecology and obstetrics.

The Division of Gynecologic Pathology at Johns Hopkins plays a vital role in the clinical diagnosis and research to advance the understanding of diseases of the female reproductive system. Five full-time faculty members of the division whose activities include clinical practice, teaching, and research closely collaborate with faculty in the Department of Gynecology/ Obstetrics. The clinical activities consist of rendering a histologic (pathologic) diagnosis on all surgical specimens removed from the female genital tract at the Johns Hopkins Hospital and outpatient clinics.

Major research efforts focus on the neurobiology/neuropathology and pathogenic mechanisms involved in a variety of illnesses, particularly the neurodegenerative diseases, including amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, and Parkinson's disease. In parallel, our group has examined in vitro and in vivo experimental systems with particular emphasis on animal models of neurodegenerative diseases.

Dr. Chien-Fu Hung is an associate professor of pathology and oncology and a professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine. He is a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on the prevention and treatment of cervical and ovarian cancers.

Carolyn Sufrin, M.D., Ph.D., is an associate professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine and of health, behavior, and society at the Johns Hopkins Bloomberg School of Public Health. As an obstetrician and gynecologist, her areas of clinical expertise include family planning, general obstetrics and gynecologic care.

Dr. Sufrin earned an undergraduate degree in anthropology at Amherst College, followed by a medical degree at the Johns Hopkins University School of Medicine. She completed residency training at Magee-Womens Hospital of University of Pittsburgh Medical Center, as well as a fellowship in family planning at the University of California, San Francisco. While at the University of California, she also earned a doctorate in medical anthropology.

Before joining the Johns Hopkins faculty in 2014, Dr. Sufrin served as assistant professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco.

She is director of the Advocacy and Research on Reproductive Wellness in Incarcerated People program, which conducts NIH- and foundation-funded research on issues such as pregnancy outcomes in prisons and jails, medication-assisted treatment for pregnant people in jails and contraception access in carceral settings.

Dr. Sufrin serves on the board of the National Commission on Correctional Health Care. She is a fellow of the American College of Obstetricians and Gynecologists and of the Society of Family Planning.

Goshin LS, Sissoko DRG, Neumann G, Sufrin C, Byrnes L. Perinatal Nurses' Experiences With and Knowledge of the Care of Incarcerated Women During Pregnancy and the Postpartum Period. J Obstet Gynecol Neonatal Nurs. 2019 Jan;48(1):27-36.

"Although our survey reached only a fraction of the approximately 5,000 OB/GYN residents in the United States, our results suggest that to serve a fast-growing population of aging women in the boomer generation and beyond, OB/GYN residency programs need to address this training gap," says senior investigator Wen Shen, an assistant professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine and a board-certified gynecologist who specializes in treating menopausal women. "Residents who participated in our study have stressed that they want more knowledge and experience in this field, and an improved comfort level in treating menopausal symptoms."

The 2010 U.S. census estimates a population of 50 million menopausal women by 2020, an average age of menopause at 51, and a life expectancy for American women of 85. Consequently, Shen notes, an enormous group of women will live one-third of their lives after menopause.

The study used a Web-based survey emailed to 258 OB/GYN residency-training directors identified by the Council on Resident Education in Obstetrics and Gynecology. The training directors were asked to forward the assessment to their residents and confirm that they had done so. Among the 510 residents who responded, only 100 reported that their program had a formal menopause-learning curriculum, and 78 said they had a defined menopause clinic as part of their residency.

"It's clear from the results that the residents who responded admit that their knowledge and clinical management skills of menopause medicine are inadequate," says lead study author Mindy S. Christianson, a clinical fellow in the Division of Reproductive Endocrinology and Infertility in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine.

"Our study has limitations, and the largest was the low response rate from residency program directors and the residents," Shen says. "Nonetheless, a majority of our study respondents indicated they were barely comfortable in managing women with menopause-specific problems."

Other researchers in the study were Jennifer A. Ducie, a former OB/GYN resident at Johns Hopkins and now a GYN/oncology fellow at Memorial Sloan-Kettering in New York City; Kristiina Altman, an assistant professor of gynecology and obstetrics at Johns Hopkins; and Ayatallah M. Khafagy, of the Johns Hopkins Bloomberg School of Public Health.

BACKGROUND

Carolyn Sufrin, M.D., Ph.D., is an assistant professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine and of health, behavior, and society at the Johns Hopkins Bloomberg School of Public Health. As a board-certified obstetrician and gynecologist, her areas of clinical expertise include family planning, general obstetrics and gynecologic care.

Dr. Irina Burd is the Sylvan Frieman, MD Endowed Professor of Obstetrics, Gynecology & Reproductive Sciences, and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Maryland. Her areas of clinical expertise include high-risk pregnancy conditions and fetal brain development. Dr. Burd earned her undergraduate degree from Rutgers University. She completed the combined M.D./Ph.D. program at the Rutgers University-Robert Wood Johnson Medical School. She completed her residency in obstetrics and gynecology at the Thomas Jefferson University Hospital and performed a fellowship in maternal-fetal medicine at the University of Pennsylvania. Dr. Burd was recruited to the University of Maryland from the Johns Hopkins University, where Dr. Burd rose through the ranks from Assistant Professor to Full Professor.

Novak CM, Lee JY, Ozen M, Tsimis ME, Kucirka LM, McLane MW, Xie L, Kelleher M, Xie H Jia B, Lei J, Burd I. Increased placental T-cell trafficking results in adverse neurobehavioral outcomes in offspring exposed to sub-chronic maternal inflammation. Brain, Behavior, and Immunity

Board certified Maternal Fetal Medicine physician with full scope of practice, dedicating 20% to clinical care with clinical expertise in fetal neurosonology and fetal echocardiography. Development of Fetal Neurosonology program at the Johns Hopkins Hospital generated referral nationally and internationally. Research focus is in fetal programing (immune and neuroimmune) with exposure to intrauterine inflammation and infection.

The major goal of this study is to explore nanomedicine approaches to address fundamental questions regarding route of administration, pharmacokinetics, as well as validating existing drug classes that may be reformulated and repurposed for improved targeting to the female reproductive tract. If these preclinical studies progress as expected, we will have identified novel, effective methods for prevention of inflammation-induced preterm birth that also support fetal and neonatal immunological and neuro-immunological programming and development.

The Healthy Brain and Child Development National Consortium (HBCD-NC) will follow 7,500 mothers and their children from 24 locations across the U.S. from before birth to 10 years of age to better understand which harmful and protective environments exert the greatest impact on child development. This study will help to improve the health and development of children across the nation.

The major goals of this project is to train Saudi Arabian physicians to conduct research through 1-2 year full time positions, to conduct collaborative projects through other departments within institution and other institutions in order to increase the scientific output and funding.

Effect of pharmacologic interventions on inflammation-induced brain injury in a preterm labor murine model: Long term neurologic implications of intrauterine magnesium sulfate and betamethasone exposure

Association of Professors of Gynecology and Obstetrics (APGO) Medical Education Endowment Fund Grant Program to develop a series of short videos with companion teaching scripts covering basic sciences topics to vertically integrate into the Obstetrics and Gynecology Clerkshi

[NO NUMBER]

$50,000

PI: Hueppchen

Co-I, 2%

Roxanne Jamshidi, M.D., MPH, is board-certified in Obstretrics & Gynecology. She is an Associate Professor of Obstetrics & Gynecology at the George Washington University School of Medicine & Health Sciences and the Director of the Division of General Obstetrics & Gynecology. She completed her medical degree from Vanderbilt University in Nashville Tennessee, followed by her residency in obstetrics & gynecology from Women and Infants Hospital at the Brown University School of Medicine in Providence Rhode Island. Dr. Jamshidi went on to complete a masters in public health from Johns Hopkins University Bloomberg School of Public Health while completing a fellowship in Family Planning from the Johns Hopkins University as well.

3a8082e126